A new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.